|
시장보고서
상품코드
2088817
의료용 산소발생기 및 산소 실린더 시장 : 제품 유형, 유량 유형, 기술, 용도, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)Medical Oxygen Concentrators & Oxygen Cylinders Market by Product Type, Flow Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032 |
||||||
360iResearch
의료용 산소발생기 및 산소 실린더 시장은 2032년까지 연평균 복합 성장률(CAGR) 9.14%로 성장해 73억 9,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 40억 1,000만 달러 |
| 추정 연도(2026년) | 43억 5,000만 달러 |
| 예측 연도(2032년) | 73억 9,000만 달러 |
| CAGR(%) | 9.14% |
의료용 산소발생기 및 산소 실린더 시장은 병원, 재택치료, 응급 의료, 장기 호흡 관리 등 각 부문에서 신뢰할 수 있는 산소 요법에 대한 전 세계적인 수요에 의해 형성되고 있습니다. 산소는 세계보건기구(WHO)에 의해 필수 의약품으로 지정되어 있으며, 저산소혈증, 만성 폐쇄성 폐질환(COPD), 폐렴, 천식 악화, 수면 관련 호흡 장애, 수술 전후 관리, 급성기 이후 회복 과정에서 임상적 중요성이 강조되고 있습니다.
산소 공급 방식은 시설 중심공급에서 병원의 산소 시스템, 재택 산소 요법, 휴대용 기기, 응급 시 산소 실린더를 활용한 백업 체계를 결합한 하이브리드형 케어 모델로 점차 전환되고 있습니다. 코로나19 대유행으로 인해 산소 공급망, 산소통 물류, 충전 네트워크, 전력 안정성, 수요 급증 시 대응 능력 계획의 취약점이 드러난 것을 계기로, 의료 시스템에서는 산소에 대한 지속적인 접근을 최우선 과제로 삼고 있습니다.
인공지능(AI)은 예측 유지보수, 수요 계획, 장비군의 가동률 최적화, 재고 최적화, 원격 환자 관리를 통해 의료용 산소 생태계에 영향을 미치기 시작하고 있습니다. AI를 활용한 분석을 통해 의료 서비스 제공업체는 장비 고장 위험을 파악하고, 가스통 배송 경로를 최적화하며, 충전 수요를 예측하고, 농축기의 성능을 모니터링하여 피할 수 있는 치료 중단을 줄일 수 있습니다.
아시아태평양은 호흡기 질환으로 인한 막대한 부담, 병원 인프라의 급속한 확충, 의료 관광 증가, 산소 생산 능력 및 중환자 치료 능력에 대한 정부 투자를 배경으로 시장이 확대되고 있습니다. 중국, 인도, 일본, 한국, 호주, 아세안(ASEAN)의 의료 시스템에서는 특히 도시 지역의 병원, 2차 의료시설, 지방의 전원 시스템, 확대되고 있는 재택치료 채널에서 휴대용 산소발생기와 신뢰성이 높은 실린더 네트워크에 대한 수요가 모두 증가하고 있습니다.
아세안 시장에서는 각국 정부가 병원의 수용 능력, 지역 돌봄, 비상 대응 체계, 의료기기 접근성을 확대하는 한편, 민간 사업자들이 휴대용 산소 기기와 재택 호흡 관리 서비스 제공을 확대함에 따라 시장이 성장하고 있습니다. GCC 지역에서는 첨단 병원, 재택치료, 응급 대응 인프라, 의료용 가스 시스템에 대한 투자가 진행되고 있으며, 고급형 산소발생기, 실린더, 조절기, 유지보수 서비스, 장기 서비스 계약에 대한 수요가 발생하고 있습니다.
미국에서는 재택 산소 요법, 병원을 통한 구매, 응급 의료 서비스, 성숙한 내구성 의료장비 생태계를 통해 수요가 주도되고 있습니다. 한편, 캐나다에서는 지리적으로 흩어져 사는 주민들에게 확실하게 접근할 수 있도록 하는 것과 만성 호흡기 질환에 대한 지속적인 치료가 중시되고 있습니다. 멕시코와 브라질에서는 민간 의료 서비스의 확대, 공립 병원의 시설 현대화, 호흡기 질환 관리 수요, 비상사태 대비 체계 개선에 따라 산소 장비 도입이 증가하고 있습니다.
업계 리더는 더 가벼운 휴대용 산소발생기, 에너지 효율이 뛰어난 고정형 장치, 네트워크 연결형 모니터링, 검증된 경보 시스템, 비상 상황에서의 내구성을 고려하여 설계된 실린더 시스템에 대한 투자를 통해 혁신성과 신뢰성 사이의 균형을 맞추어야 합니다. 제조업체와 판매업체는 압축기, 분자 체 베드, 밸브, 조절기, 배터리, 센서, 필터, 가습 부품, 의료용 실린더에 대해 이중화된 공급망을 구축하여 공급 중단 위험을 줄여야 합니다.
본 요약본은 2차 조사, 공중보건 관련 증거, 규제 당국의 심사, 제품 및 기술 평가, 그리고 시장 구조 분석을 바탕으로 작성되었습니다. 정보 출처로는 세계보건기구(WHO), 각국의 보건 기관, 의료기기 규제 당국, 보험 급여 기관, 병원의 조달 동향, 표준화 단체, 제품 문서, 동료 심사를 거친 호흡 관리 관련 문헌 등 신뢰성이 높은 정보 출처가 활용되고 있습니다.
의료용 산소발생기 및 산소 실린더 시장은 상호 연계가 더욱 강화되고, 회복탄력성을 갖추며, 환자 중심의 모델로 전환되고 있습니다. 만성 호흡기 질환, 고령화, 병원의 대비 태세, 응급의료 요건, 재택의료의 확대가 선진국과 신흥국 모두에서 수요를 지속적으로 뒷받침하고 있습니다.
The Medical Oxygen Concentrators & Oxygen Cylinders Market is projected to grow by USD 7.39 billion at a CAGR of 9.14% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 4.01 billion |
| Estimated Year [2026] | USD 4.35 billion |
| Forecast Year [2032] | USD 7.39 billion |
| CAGR (%) | 9.14% |
The medical oxygen concentrators and oxygen cylinders market is shaped by the global need for reliable oxygen therapy across hospitals, home healthcare, emergency medicine, and long-term respiratory care. Oxygen is listed by the World Health Organization as an essential medicine, underscoring its clinical importance for hypoxemia, chronic obstructive pulmonary disease, pneumonia, asthma exacerbations, sleep-related breathing disorders, perioperative care, and post-acute recovery.
Demand is supported by aging populations, high chronic respiratory disease prevalence, broader home-based care adoption, and the need for resilient medical gas infrastructure. Stationary oxygen concentrators, portable oxygen concentrators, compressed oxygen cylinders, cryogenic oxygen systems, regulators, flowmeters, humidifiers, cannulas, and related accessories remain central to care delivery because they address different clinical, mobility, cost, continuity, and backup-power requirements.
The landscape is shifting from facility-centered oxygen delivery toward hybrid care models that combine hospital oxygen systems, home oxygen therapy, portable devices, and emergency cylinder backup. Healthcare systems are prioritizing continuity of oxygen access after COVID-19 exposed vulnerabilities in oxygen supply chains, cylinder logistics, refill networks, power reliability, and surge-capacity planning.
Product innovation is also changing competition. Portable oxygen concentrators with longer battery life, lighter form factors, pulse-dose technologies, improved sieve-bed efficiency, remote monitoring, and lower noise levels are gaining importance. At the same time, cylinders remain indispensable for ambulance services, disaster response, high-flow backup, perioperative support, and settings where electricity reliability or device maintenance constraints limit concentrator use.
Artificial intelligence is beginning to influence the medical oxygen ecosystem through predictive maintenance, demand planning, fleet utilization, inventory optimization, and remote patient management. AI-enabled analytics can help providers identify device malfunction risks, optimize cylinder delivery routes, anticipate refill needs, monitor concentrator performance, and reduce avoidable therapy interruptions.
In clinical workflows, AI-supported monitoring may improve adherence by analyzing oxygen use patterns, saturation trends from connected pulse oximeters, alarm events, battery performance, and device utilization data. The cumulative impact is strongest where AI is integrated with connected concentrators, durable medical equipment operations, hospital asset management, logistics planning, and reimbursement documentation while maintaining data privacy and clinical validation standards.
Asia-Pacific is expanding on the back of large respiratory disease burdens, fast hospital infrastructure development, rising medical tourism, and government investment in oxygen generation and critical-care capacity. China, India, Japan, South Korea, Australia, and ASEAN healthcare systems are increasing demand for both portable oxygen concentrators and reliable cylinder networks, especially across urban hospitals, secondary-care facilities, rural referral systems, and growing homecare channels.
North America remains a high-value oxygen equipment market due to established reimbursement pathways, sophisticated durable medical equipment distribution, high home oxygen therapy adoption, and strong emergency medical services coverage. Europe benefits from universal healthcare systems, aging demographics, structured procurement, and regulatory emphasis on safety and post-market surveillance under the European medical device framework. Latin America shows rising demand linked to private healthcare expansion, public hospital upgrades, and improved respiratory disease management, while the Middle East is supported by advanced hospital development, home healthcare growth, and emergency preparedness programs. Africa continues to prioritize dependable oxygen access, cylinder distribution, concentrator maintenance, and infrastructure support in underserved and remote care settings.
ASEAN markets are advancing as governments expand hospital capacity, community care, emergency preparedness, and medical device access, while private providers increase availability of portable oxygen devices and home respiratory services. GCC countries are investing in advanced hospitals, home healthcare, emergency response infrastructure, and medical gas systems, creating demand for premium concentrators, cylinders, regulators, maintenance services, and long-term service contracts.
The European Union is shaped by harmonized regulatory requirements, sustainability objectives, health technology assessment practices, and strong procurement standards. BRICS countries represent scale-driven opportunity because of large populations, respiratory disease prevalence, domestic manufacturing capabilities, and ongoing healthcare infrastructure investments. G7 markets emphasize clinical quality, reimbursement compliance, connected care, data security, preventive maintenance, and reliable durable medical equipment services. NATO countries add demand considerations tied to emergency readiness, field medicine, disaster response, military medical logistics, and resilient oxygen supply chains.
The United States leads demand through home oxygen therapy, hospital purchasing, emergency medical services, and a mature durable medical equipment ecosystem, while Canada emphasizes reliable access across geographically dispersed populations and continuity of care for chronic respiratory disease. Mexico and Brazil show increasing oxygen equipment adoption through private healthcare expansion, public hospital upgrades, respiratory disease management needs, and emergency preparedness improvements.
In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from aging populations, structured reimbursement, hospital modernization, and established respiratory care pathways, while Russia relies on hospital procurement, regional distribution networks, and public-sector healthcare requirements. China and India are major growth engines due to population scale, domestic manufacturing, expanding hospital oxygen infrastructure, and broadening access to homecare and portable oxygen technologies. Japan, Australia, and South Korea demonstrate demand for high-quality portable concentrators, clinically validated respiratory technologies, compact device designs, homecare integration, and dependable after-sales support.
Industry leaders should balance innovation with reliability by investing in lighter portable oxygen concentrators, energy-efficient stationary units, connected monitoring, validated alarms, and cylinder systems designed for emergency resilience. Manufacturers and distributors should build redundant supply chains for compressors, molecular sieve beds, valves, regulators, batteries, sensors, filters, humidification components, and medical-grade cylinders to reduce disruption risk.
Commercial strategies should align products with local reimbursement, clinical protocols, quality standards, and service expectations. Organizations can strengthen competitiveness through clinical education, preventive maintenance programs, remote troubleshooting, rental and subscription models, documented compliance support, and partnerships with hospitals, homecare providers, pharmacies, emergency services, public health agencies, and government oxygen programs.
This executive summary is based on secondary research, public health evidence, regulatory review, product and technology assessment, and market-structure analysis. Inputs include recognized sources such as the World Health Organization, national health agencies, medical device regulators, reimbursement authorities, hospital procurement signals, standards bodies, product documentation, and peer-reviewed respiratory care literature.
The research framework evaluates demand drivers, therapy settings, product categories, regional healthcare capacity, policy environments, supply-chain dependencies, technology adoption, service models, and clinical use cases. Findings are validated through triangulation across clinical need, purchasing behavior, installed base dynamics, regulatory requirements, and competitive positioning to ensure practical relevance for decision-makers without relying on market sizing or forecasting.
The medical oxygen concentrators and oxygen cylinders market is moving toward a more connected, resilient, and patient-centered model. Chronic respiratory disease, aging populations, hospital preparedness, emergency care requirements, and home healthcare expansion continue to support demand across both advanced and emerging economies.
Future leadership will depend on dependable product performance, intelligent service models, regulatory compliance, supply-chain resilience, and the ability to serve diverse care settings. Organizations that combine portable innovation, robust cylinder logistics, AI-enabled operations, maintenance excellence, and regional market adaptation will be best positioned to support long-term oxygen therapy access.